These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 894521)

  • 1. Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats.
    Gregg RA; Baumann MH; Partilla JS; Bonano JS; Vouga A; Tallarida CS; Velvadapu V; Smith GR; Peet MM; Reitz AB; Negus SS; Rawls SM
    Br J Pharmacol; 2015 Feb; 172(3):883-94. PubMed ID: 25255824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How addictive drugs disrupt presynaptic dopamine neurotransmission.
    Sulzer D
    Neuron; 2011 Feb; 69(4):628-49. PubMed ID: 21338876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
    Horton DB; Siripurapu KB; Norrholm SD; Culver JP; Hojahmat M; Beckmann JS; Harrod SB; Deaciuc AG; Bardo MT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2011 Mar; 336(3):940-51. PubMed ID: 21177475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral sensitization and tolerance to cocaine and the occupation of dopamine receptors by dopamine.
    Martin-Iverson MT; Burger LY
    Mol Neurobiol; 1995; 11(1-3):31-46. PubMed ID: 8561966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.
    Hegadoren KM; Greenshaw AJ; Baker GB; Martin-Iverson MT; Lodge B; Soin S
    J Psychiatry Neurosci; 1994 Jan; 19(1):57-62. PubMed ID: 8148367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
    Fitzgerald JL; Reid JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):313-23. PubMed ID: 8097569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of endogenous monoamines and amino acids from several CNS regions of the rat.
    McBride WJ; Flint RS; Ciancone MT; Murphy JM
    Neurochem Res; 1983 Feb; 8(2):245-57. PubMed ID: 6856029
    [No Abstract]   [Full Text] [Related]  

  • 8. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
    Radhakishun FS; Korf J; Venema K; Westerink BH
    Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo.
    Philips SR; Robson AM
    Neurochem Res; 1983 Jun; 8(6):731-41. PubMed ID: 6621771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carbamazepine and anti-depressant drugs on endogenous catecholamine levels in the cerebroventricular compartment of the rat.
    Kowalik S; Levitt M; Barkai AI
    Psychopharmacology (Berl); 1984; 83(2):169-71. PubMed ID: 6431468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of noradrenergic system in a remarkably rapid tongue clonus produced by acute hypnotic doses of ethanol in Fischer F344 rats.
    Menon MK; Lloyd RL
    Psychopharmacology (Berl); 1989; 99(4):497-500. PubMed ID: 2594916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats.
    Kolta MG; Scalzo FM; Ali SF; Holson RR
    Psychopharmacology (Berl); 1990; 100(3):377-82. PubMed ID: 2315435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
    Martin-Iverson MT; Yamada N; By AW; Lodge BA
    J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway.
    Bunney BS; Aghajanian GK
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):255-61. PubMed ID: 714182
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of central catecholamine depletion on the osmotic and nonosmotic stimulation of vasopressin (antidiuretic hormone) in the rat.
    Miller TR; Handelman WA; Arnold PE; McDonald KM; Molinoff PB; Schrier RW
    J Clin Invest; 1979 Dec; 64(6):1599-607. PubMed ID: 500827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine's locomotor-stimulant and noreprinephrine-releasing effects: evidence for selective antagonism by nisoxetine.
    Tyler TD; Tessel RE
    Psychopharmacology (Berl); 1979 Sep; 64(3):291-6. PubMed ID: 41278
    [No Abstract]   [Full Text] [Related]  

  • 17. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of amphetamine-induced release of norepinephrine from rat cerebral cortex in vitro.
    Ziance RJ; Azzaro AJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Aug; 182(2):284-94. PubMed ID: 5048365
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.